カテゴリー： GlobalInfoResearch, 世界

全身麻酔薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global General Anaesthesia Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9101944）・商品コード：GIR9101944
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月16日（※2024年版があります。お問い合わせください）
・ページ数：122
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、全身麻酔薬の世界市場について調べ、まとめました。種類別セグメントは、プロポフォール、セボフルラン、イソフルラン、デクスメデトミジン、デスフルラン、レミフェンタニル、ミダゾラム、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。全身麻酔薬の世界市場概観、企業動向、企業別全身麻酔薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・全身麻酔薬の市場概観
・全身麻酔薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・全身麻酔薬の企業別販売動向、市場シェア、市場集中度、競争動向
・全身麻酔薬の世界市場規模
・全身麻酔薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・全身麻酔薬のアメリカ市場規模推移
・全身麻酔薬のカナダ市場規模推移
・全身麻酔薬のメキシコ市場規模推移
・全身麻酔薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・全身麻酔薬のドイツ市場規模推移
・全身麻酔薬のイギリス市場規模推移
・全身麻酔薬のロシア市場規模推移
・全身麻酔薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・全身麻酔薬の日本市場規模推移
・全身麻酔薬の中国市場規模推移
・全身麻酔薬の韓国市場規模推移
・全身麻酔薬のインド市場規模推移
・全身麻酔薬の東南アジア市場規模推移
・全身麻酔薬の南米市場分析（ブラジル、アルゼンチン等）
・全身麻酔薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・全身麻酔薬の種類別分析/販売量、売上、市場シェア（プロポフォール、セボフルラン、イソフルラン、デクスメデトミジン、デスフルラン、レミフェンタニル、ミダゾラム、その他）
・全身麻酔薬の用途別分析/市場規模（病院、診療所、その他）
・全身麻酔薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・全身麻酔薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

General Anaesthesia Drugs act on the central nervous system, inducing a sedative state in patients who are to go through a surgical procedure.

Scope of the Report:
The global General Anaesthesia Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of General Anaesthesia Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the General Anaesthesia Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the General Anaesthesia Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers
Baxter International
AstraZeneca
Abbott Laboratories
Roche
Fresenius
Mylan
Eisai
Hospira
Hikma Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Propofol
Sevoflurane
Isoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
Others

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

【レポートの目次】

Table of Contents

1 General Anaesthesia Drugs Market Overview
1.1 Product Overview and Scope of General Anaesthesia Drugs
1.2 Classification of General Anaesthesia Drugs by Types
1.2.1 Global General Anaesthesia Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global General Anaesthesia Drugs Revenue Market Share by Types in 2018
1.2.3 Propofol
1.2.4 Sevoflurane
1.2.5 Isoflurane
1.2.6 Dexmedetomidine
1.2.7 Desflurane
1.2.8 Remifentanil
1.2.9 Midazolam
1.2.10 Others
1.3 Global General Anaesthesia Drugs Market by Application
1.3.1 Global General Anaesthesia Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global General Anaesthesia Drugs Market by Regions
1.4.1 Global General Anaesthesia Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) General Anaesthesia Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) General Anaesthesia Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) General Anaesthesia Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) General Anaesthesia Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) General Anaesthesia Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of General Anaesthesia Drugs (2014-2024)
2 Manufacturers Profiles
2.1 Baxter International
2.1.1 Business Overview
2.1.2 General Anaesthesia Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Baxter International General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 General Anaesthesia Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Abbott Laboratories
2.3.1 Business Overview
2.3.2 General Anaesthesia Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Laboratories General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roche
2.4.1 Business Overview
2.4.2 General Anaesthesia Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Fresenius
2.5.1 Business Overview
2.5.2 General Anaesthesia Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Fresenius General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Mylan
2.6.1 Business Overview
2.6.2 General Anaesthesia Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mylan General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 Eisai
2.7.1 Business Overview
2.7.2 General Anaesthesia Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eisai General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.8 Hospira
2.8.1 Business Overview
2.8.2 General Anaesthesia Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hospira General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.9 Hikma Pharmaceuticals
2.9.1 Business Overview
2.9.2 General Anaesthesia Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hikma Pharmaceuticals General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global General Anaesthesia Drugs Market Competition, by Players
3.1 Global General Anaesthesia Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 General Anaesthesia Drugs Players Market Share
3.2.2 Top 10 General Anaesthesia Drugs Players Market Share
3.3 Market Competition Trend
4 Global General Anaesthesia Drugs Market Size by Regions
4.1 Global General Anaesthesia Drugs Revenue and Market Share by Regions
4.2 North America General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
4.5 South America General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
5 North America General Anaesthesia Drugs Revenue by Countries
5.1 North America General Anaesthesia Drugs Revenue by Countries (2014-2019)
5.2 USA General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
6 Europe General Anaesthesia Drugs Revenue by Countries
6.1 Europe General Anaesthesia Drugs Revenue by Countries (2014-2019)
6.2 Germany General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
6.3 UK General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
6.4 France General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific General Anaesthesia Drugs Revenue by Countries
7.1 Asia-Pacific General Anaesthesia Drugs Revenue by Countries (2014-2019)
7.2 China General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
7.5 India General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
8 South America General Anaesthesia Drugs Revenue by Countries
8.1 South America General Anaesthesia Drugs Revenue by Countries (2014-2019)
8.2 Brazil General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue General Anaesthesia Drugs by Countries
9.1 Middle East and Africa General Anaesthesia Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
10 Global General Anaesthesia Drugs Market Segment by Type
10.1 Global General Anaesthesia Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global General Anaesthesia Drugs Market Forecast by Type (2019-2024)
10.3 Propofol Revenue Growth Rate (2014-2024)
10.4 Sevoflurane Revenue Growth Rate (2014-2024)
10.5 Isoflurane Revenue Growth Rate (2014-2024)
10.6 Dexmedetomidine Revenue Growth Rate (2014-2024)
10.7 Desflurane Revenue Growth Rate (2014-2024)
10.8 Remifentanil Revenue Growth Rate (2014-2024)
10.9 Midazolam Revenue Growth Rate (2014-2024)
10.10 Others Revenue Growth Rate (2014-2024)
11 Global General Anaesthesia Drugs Market Segment by Application
11.1 Global General Anaesthesia Drugs Revenue Market Share by Application (2014-2019)
11.2 General Anaesthesia Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global General Anaesthesia Drugs Market Size Forecast (2019-2024)
12.1 Global General Anaesthesia Drugs Market Size Forecast (2019-2024)
12.2 Global General Anaesthesia Drugs Market Forecast by Regions (2019-2024)
12.3 North America General Anaesthesia Drugs Revenue Market Forecast (2019-2024)
12.4 Europe General Anaesthesia Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific General Anaesthesia Drugs Revenue Market Forecast (2019-2024)
12.6 South America General Anaesthesia Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa General Anaesthesia Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure General Anaesthesia Drugs Picture
Table Product Specifications of General Anaesthesia Drugs
Table Global General Anaesthesia Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global General Anaesthesia Drugs Revenue Market Share by Types in 2018
Figure Propofol Picture
Figure Sevoflurane Picture
Figure Isoflurane Picture
Figure Dexmedetomidine Picture
Figure Desflurane Picture
Figure Remifentanil Picture
Figure Midazolam Picture
Figure Others Picture
Table Global General Anaesthesia Drugs Revenue (Million USD) by Application (2014-2024)
Figure General Anaesthesia Drugs Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market General Anaesthesia Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America General Anaesthesia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe General Anaesthesia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific General Anaesthesia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America General Anaesthesia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa General Anaesthesia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global General Anaesthesia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Baxter International Basic Information, Manufacturing Base and Competitors
Table Baxter International General Anaesthesia Drugs Type and Applications
Table Baxter International General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca General Anaesthesia Drugs Type and Applications
Table AstraZeneca General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories General Anaesthesia Drugs Type and Applications
Table Abbott Laboratories General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche General Anaesthesia Drugs Type and Applications
Table Roche General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Fresenius Basic Information, Manufacturing Base and Competitors
Table Fresenius General Anaesthesia Drugs Type and Applications
Table Fresenius General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan General Anaesthesia Drugs Type and Applications
Table Mylan General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai General Anaesthesia Drugs Type and Applications
Table Eisai General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Hospira Basic Information, Manufacturing Base and Competitors
Table Hospira General Anaesthesia Drugs Type and Applications
Table Hospira General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Hikma Pharmaceuticals General Anaesthesia Drugs Type and Applications
Table Hikma Pharmaceuticals General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global General Anaesthesia Drugs Revenue (Million USD) by Players (2014-2019)
Table Global General Anaesthesia Drugs Revenue Share by Players (2014-2019)
Figure Global General Anaesthesia Drugs Revenue Share by Players in 2017
Figure Global General Anaesthesia Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players General Anaesthesia Drugs Revenue Market Share in 2018
Figure Global Top 10 Players General Anaesthesia Drugs Revenue Market Share in 2018
Figure Global General Anaesthesia Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global General Anaesthesia Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global General Anaesthesia Drugs Revenue Market Share by Regions (2014-2019)
Figure Global General Anaesthesia Drugs Revenue Market Share by Regions (2014-2019)
Figure Global General Anaesthesia Drugs Revenue Market Share by Regions in 2018
Figure North America General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Europe General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure South America General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Table North America General Anaesthesia Drugs Revenue by Countries (2014-2019)
Table North America General Anaesthesia Drugs Revenue Market Share by Countries (2014-2019)
Figure North America General Anaesthesia Drugs Revenue Market Share by Countries (2014-2019)
Figure North America General Anaesthesia Drugs Revenue Market Share by Countries in 2018
Figure USA General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Canada General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Table Europe General Anaesthesia Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe General Anaesthesia Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe General Anaesthesia Drugs Revenue Market Share by Countries in 2018
Figure Germany General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure UK General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure France General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Russia General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Italy General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific General Anaesthesia Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific General Anaesthesia Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific General Anaesthesia Drugs Revenue Market Share by Countries in 2018
Figure China General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Japan General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Korea General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure India General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Table South America General Anaesthesia Drugs Revenue by Countries (2014-2019)
Table South America General Anaesthesia Drugs Revenue Market Share by Countries (2014-2019)
Figure South America General Anaesthesia Drugs Revenue Market Share by Countries (2014-2019)
Figure South America General Anaesthesia Drugs Revenue Market Share by Countries in 2018
Figure Brazil General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa General Anaesthesia Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa General Anaesthesia Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa General Anaesthesia Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa General Anaesthesia Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure UAE General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa General Anaesthesia Drugs Revenue and Growth Rate (2014-2019)
Table Global General Anaesthesia Drugs Revenue (Million USD) by Type (2014-2019)
Table Global General Anaesthesia Drugs Revenue Share by Type (2014-2019)
Figure Global General Anaesthesia Drugs Revenue Share by Type (2014-2019)
Figure Global General Anaesthesia Drugs Revenue Share by Type in 2019
Table Global General Anaesthesia Drugs Revenue Forecast by Type (2019-2024)
Figure Global General Anaesthesia Drugs Market Share Forecast by Type (2019-2024)
Figure Global Propofol Revenue Growth Rate (2014-2019)
Figure Global Sevoflurane Revenue Growth Rate (2014-2019)
Figure Global Isoflurane Revenue Growth Rate (2014-2019)
Figure Global Dexmedetomidine Revenue Growth Rate (2014-2019)
Figure Global Desflurane Revenue Growth Rate (2014-2019)
Figure Global Remifentanil Revenue Growth Rate (2014-2019)
Figure Global Midazolam Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global General Anaesthesia Drugs Revenue by Application (2014-2019)
Table Global General Anaesthesia Drugs Revenue Share by Application (2014-2019)
Figure Global General Anaesthesia Drugs Revenue Share by Application (2014-2019)
Figure Global General Anaesthesia Drugs Revenue Share by Application in 2019
Table Global General Anaesthesia Drugs Revenue Forecast by Application (2019-2024)
Figure Global General Anaesthesia Drugs Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global General Anaesthesia Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global General Anaesthesia Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global General Anaesthesia Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America General Anaesthesia Drugs Revenue Market Forecast (2019-2024)
Figure Europe General Anaesthesia Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific General Anaesthesia Drugs Revenue Market Forecast (2019-2024)
Figure South America General Anaesthesia Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa General Anaesthesia Drugs Revenue Market Forecast (2019-2024)


【掲載企業】

Baxter International、AstraZeneca、Abbott Laboratories、Roche、Fresenius、Mylan、Eisai、Hospira、Hikma Pharmaceuticals、

★調査レポート[全身麻酔薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9101944)販売に関する免責事項を必ずご確認ください。
★調査レポート[全身麻酔薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 高血圧薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101665 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、高血圧薬の世界市場について調べ、まとめました。種類別セグメントは、利尿降圧薬、交感神経抑制薬、レニン-アンジオテンシン系阻害薬、カルシウム拮抗薬、血管拡張薬等、用途別セグメントは、老人、妊婦、一般患者等に区分しました。高血圧薬の世界市場概観、メーカー動向、メーカー別高血圧薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・高血圧薬の市場概観 ・高血圧薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・高血圧薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・高血圧薬の世界市場規模 ・高血圧薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・高血圧薬のアメリカ市場規模推移 ・高血圧薬のカナダ市場規模推移 ・高血圧薬のメキシコ市場規模推移 ・高血圧薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Antihypertensive drug is a kind of medicine that can control blood pressure and is used to treat hypertension. Scope of the Report: The worldwide market for Antihypertensive Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Antihypertensive Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application....
  • 神経芽腫薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102908 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、神経芽腫薬の世界市場について調べ、まとめました。種類別セグメントは、化学療法、免疫療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。神経芽腫薬の世界市場概観、企業動向、企業別神経芽腫薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・神経芽腫薬の市場概観 ・神経芽腫薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・神経芽腫薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・神経芽腫薬の世界市場規模 ・神経芽腫薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・神経芽腫薬のアメリカ市場規模推移 ・神経芽腫薬のカナダ市場規模推移 ・神経芽腫薬のメキシコ市場規模推移 ・神経芽腫薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands, but can also develop in the neck, chest, abdomen, or spine. Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under the skin. Scope of the Report: The global Neuroblastoma Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will...
  • 間質性膀胱炎薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102907 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、間質性膀胱炎薬の世界市場について調べ、まとめました。種類別セグメントは、経口療法、膀胱内療法等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。間質性膀胱炎薬の世界市場概観、企業動向、企業別間質性膀胱炎薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・間質性膀胱炎薬の市場概観 ・間質性膀胱炎薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・間質性膀胱炎薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・間質性膀胱炎薬の世界市場規模 ・間質性膀胱炎薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・間質性膀胱炎薬のアメリカ市場規模推移 ・間質性膀胱炎薬のカナダ市場規模推移 ・間質性膀胱炎薬のメキシコ市場規模推移 ・間質性膀胱炎薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Interstitial cystitis (IC), also known as painful bladder syndrome, is a chronic bladder issue often associated with bladder pressure and pain, with occasional pain in either the lower abdomen, pelvic, or lower back. Scope of the Report: The global Interstitial Cystitis Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The...
  • 婦人科薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103384 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、婦人科薬の世界市場について調べ、まとめました。種類別セグメントは、ホルモン療法、非ホルモン療法等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。婦人科薬の世界市場概観、企業動向、企業別婦人科薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・婦人科薬の市場概観 ・婦人科薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・婦人科薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・婦人科薬の世界市場規模 ・婦人科薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・婦人科薬のアメリカ市場規模推移 ・婦人科薬のカナダ市場規模推移 ・婦人科薬のメキシコ市場規模推移 ・婦人科薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Gynecology Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gynecology Drugs. Europe also play important roles in global market,...
  • 咳止め薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103572 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、咳止め薬の世界市場について調べ、まとめました。種類別セグメントは、乾いた咳、湿った咳等、用途別セグメントは、病院、小売薬局、オンライン薬局、その他等に区分しました。咳止め薬の世界市場概観、企業動向、企業別咳止め薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・咳止め薬の市場概観 ・咳止め薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・咳止め薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・咳止め薬の世界市場規模 ・咳止め薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・咳止め薬のアメリカ市場規模推移 ・咳止め薬のカナダ市場規模推移 ・咳止め薬のメキシコ市場規模推移 ・咳止め薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Cough Suppressant, also known as cAntitussives, are widely used to relieve the symptoms of cough. They are substances which suppress the coughing itself. Examples are codeine, pholcodine, dextromethorphan, noscapine, and butamirate. Scope of the Report: The global Cough Suppressant Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States,...

    • ◆H&Iグローバルリサーチのお客様（例）◆